MYC dosage compensation is mediated by miRNA-transcription factor interactions in aneuploid cancer
M. S. Acon, C. Geiss, J. Torres-Calvo, D. Bravo-Estupinan, G. Oviedo, J. L. Arias-Arias, L. A. Rojas-Matey, E. Baez, G. Vasquez-Vargas, Y. Oses-Vargas, J. Guevara-Coto, A. Segura-Castillo, F. Siles-Canales, S. Quiros-Barrantes, A. Regnier-Vigouroux, , R. M. Mora-Rodriguez
This study identifies miRNA-transcription factor interactions that mediate MYC dosage compensation in aneuploid cancer, showing a negative correlation with patient survival in breast cancer.
bioRxiv · Apr 20, 2021Cancer Biology